Evocutis : Out licensing

Outlicensing Opportunities

Contact us to investigate further

Home » Our Company » Business development » Out licensing

Out licensing

We have an active internal R&D programme aimed at producing dermatological technologies with commercial relevance to the cosmetic and consumer healthcare markets.

If you are scouting for technologies to in-licence or looking for ways to speed up your innovation for dermatological R&D projects, we would love to hear from you.

Using our skin science expertise we have developed two key dermatological technologies. Both are at the stage where we wish to discuss partnership opportunities for their worldwide product development and marketing.

Evocutis Armere - Anti-acne product

  • Cosmetic formulation designed as a leave on night-time complex for blemish/spot prone skin
  • A substantial clinical data package demonstrates that the product significantly reduces inflamed spots, answering consumer demands for scientific proof and genuine benefits
  • Potent antibacterial activity, targeting spot-causing bacteria within the follicle
  • Unique delivery system for fast and effective penetration of actives
  • Novel: protected by 3 Evocutis patents

Click for more on Evocutis Armere  

 Active delivery system for skin care

  • Patented skin-matched delivery technology that increases efficacy of active ingredients
  • Clinically proven to penetrate follicles
  • Application areas: Anti-acne, anti-infective, hair loss

For all business development enquiries please contact: bd@evocutis.com.